Back to search
Lung Diseases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lung Diseases trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Lung Diseases trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is a randomized, open, multicenter phase III clinical study, which aims to evaluate the efficacy and safety of firmonertinib mesylate compared with p…
ARES is a multi-centre, retrospective-prospective, non-comparative and non-interventional (observational) cohort study involving primary and secondary data coll…
This study will investigate how, why and under what conditions eosinophils (a type of white blood cell) become activated and will examine their function in immu…
Evaluate the safety and tolerability, drug levels, and clinical activity of JAB-21822 in patients with locally advanced or metastatic non-small cell lung cancer…
The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episod…
This study will investigate the genetic cause of Birt Hogg-Dube (BHD) syndrome and the relationship of this disorder to kidney cancer. BHD is a rare inherited c…
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effe…
The goal of this quasi-experimental study is to analyze if a Machine Learning Clinical Decision Support System can improve the empirical antibiotic treatment in…